VYLEESI begins here with a US FDA medicine identity.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
VYLEESI begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Malaysia. Verify the exact local records below.
Resolve the exact identity of VYLEESI through Current VYLEESI prescribing information from National Library of Medicine, DailyMed. Then search QUEST3+ Product Search from National Pharmaceutical Regulatory Agency for the destination product record and Product registration FAQ from National Pharmaceutical Regulatory Agency for the seller, establishment, or supply route in Malaysia. A match in one record does not replace the other two checks.
No. A page using the name VYLEESI, local currency, a domestic delivery claim, or a familiar package image is only a lead. VYLEESI is the FDA-approved US bremelanotide 1.75 mg autoinjector with an exact application, indication, label, presentation, and regulated prescription supply chain. That approval does not transfer to seller-labelled PT-141 research vials, compounded products, imported presentations, online listings, or supply routes, and it does not establish authorization or current availability in another country. For Malaysia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
VYLEESI begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Malaysia. Verify the exact local records below.
Primary identity source: Current VYLEESI prescribing information / National Library of Medicine, DailyMed ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Current VYLEESI prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Current VYLEESI prescribing information ↗QUEST3+ Product Search is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open QUEST3+ Product Search ↗Product registration FAQ is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Product registration FAQ ↗Malaysia's NPRA distinguishes registered products from manufacturer, importer, and wholesaler licences. A MAL-looking number, hologram image, marketplace badge, research statement, or laboratory document should be matched to the current official product record and responsible entity.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use the NPRA product search with the MAL number, product name, holder, manufacturer, importer, or active ingredient, and confirm that the returned status is active at the time of the search.
Compare the registration number, product category, holder, manufacturer, dosage form, and pack to the offer. A copied MAL number or similar product name is not a complete match.
Confirm the relevant manufacturer, import, or wholesale authority independently because NPRA treats product registration and the licences for supply activities as different controls.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.